NCT07845396

Brief Summary

Since the onset of COVID-19, studies conducted on the general population have shown an increase in the use of antidepressants and anxiolytics, a rise in domestic violence, and heightened demand for peri-urban housing offering more space and a better living environment. Queues of students at food distribution points, along with the precarious situations and isolation faced by students with no alternative to cramped living quarters, have exposed the vulnerability of this population to the general public. There is a lack of data regarding young people-and students in particular-a group known to be at higher risk than others of exhibiting symptoms of stress, anxiety, or depression. Depression among students and young adults can impact their social lives, relationships, and quality of life. Indeed, studies have demonstrated a strong correlation between major depressive disorder and poor academic performance, unstable interpersonal relationships, suicidal thoughts and attempts, and difficulties with work. Existing literature indicates a link between stress and the onset or persistence of anxiety and depression. As these conditions are too often conflated, it is important to distinguish stress from anxiety and depression. Consequently, a study designed to assess levels of stress, anxiety, and depression-as well as the processes involved in their development and persistence among young people-would facilitate the implementation of appropriate and effective care. Such a study is all the more necessary in the current context of the COVID-19 pandemic. Identifying these disorders within specific populations and subgroups would enable the implementation of tailored care strategies, thereby helping to safeguard mental health. The aim of this study is to assess current levels of stress, anxiety, and depression among young adults and students, and to investigate the underlying determinants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,322

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 27, 2023

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

September 18, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 28, 2026

Completed
Last Updated

September 28, 2026

Status Verified

September 1, 2026

Enrollment Period

4 months

First QC Date

September 18, 2026

Last Update Submit

September 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perceived Stress Scale (PSS) score :

    The PSS-10 takes about 3 minutes to complete and produces a 0-40 score : * 0-13 low * 14-26 moderate * 27-40 high

    3 months

Study Arms (1)

patient between 18 and 29 years old

Other: Questionnaire

Interventions

* Generalised anxiety disorder questionnaire * Questionnaire Patient Health Questionnaire-9 (PHQ-9) * Perceived Stress Scale questionnaire * Difficulties in Emotion Regulation Scale (DERS-16) questionnaire * Acceptance and action questionnaire * Perseverative Thinking Questionnaire * D-stress questionnaire * Electrostatic discharge questionnaire

patient between 18 and 29 years old

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adult patient between 18 and 29 years old

You may qualify if:

  • Subject between 18 and 29 years of age.
  • Subject capable of understanding the information necessary for the study and participating in online surveys.
  • Has read the information sheet describing the research and agreed to participate.
  • Subject affiliated with or a beneficiary of a social security scheme.

You may not qualify if:

  • Minor subject
  • Subject aged 30 or older
  • Difficulty understanding and/or expressing themselves in French
  • Subject under legal protection measures (curatorship, guardianship, etc.) or deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding, or recently delivered woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Université de Nanterre

Nanterre, 92000, France

Location

MeSH Terms

Conditions

Anxiety DisordersCOVID-19

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Mental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2026

First Posted

September 28, 2026

Study Start

May 16, 2022

Primary Completion

September 26, 2022

Study Completion

January 27, 2023

Last Updated

September 28, 2026

Record last verified: 2026-09

Locations